198 related articles for article (PubMed ID: 19191675)
1. Pharmacotherapy of patients with schizophrenia and substance abuse.
Wobrock T; Soyka M
Expert Opin Pharmacother; 2009 Feb; 10(3):353-67. PubMed ID: 19191675
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.
Wobrock T; Soyka M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1375-85. PubMed ID: 18394768
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
Wobrock T; D'Amelio R; Falkai P
Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
[TBL] [Abstract][Full Text] [Related]
4. Management of schizophrenia with substance use disorders.
Lybrand J; Caroff S
Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
[TBL] [Abstract][Full Text] [Related]
5. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
6. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
Kalyoncu A; Mirsal H; Pektas O; Unsalan N; Tan D; Beyazyürek M
J Psychopharmacol; 2005 May; 19(3):301-5. PubMed ID: 15888516
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis.
Krause M; Huhn M; Schneider-Thoma J; Bighelli I; Gutsmiedl K; Leucht S
Eur Neuropsychopharmacol; 2019 Jan; 29(1):32-45. PubMed ID: 30472164
[TBL] [Abstract][Full Text] [Related]
8. Substance abuse and schizophrenia: pharmacotherapeutic intervention.
Green AI; Noordsy DL; Brunette MF; O'Keefe C
J Subst Abuse Treat; 2008 Jan; 34(1):61-71. PubMed ID: 17574793
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment of schizophrenia with comorbid substance use disorder.
Azorin JM; Simon N; Adida M; Belzeaux R
Expert Opin Pharmacother; 2016; 17(2):231-53. PubMed ID: 26635059
[TBL] [Abstract][Full Text] [Related]
10. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
Arranz B; Garriga M; García-Rizo C; San L
Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
[TBL] [Abstract][Full Text] [Related]
11. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia.
Buckley PF
J Subst Abuse Treat; 1998; 15(2):113-6. PubMed ID: 9561949
[TBL] [Abstract][Full Text] [Related]
12. Long-term Administration of Antipsychotic Drugs in Schizophrenia and Influence of Substance and Drug Abuse on the Disease Outcome.
Werner FM; Covenas R
Curr Drug Abuse Rev; 2017; 10(1):19-24. PubMed ID: 29065847
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
Green AI
J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
[TBL] [Abstract][Full Text] [Related]
14. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
15. [Polypharmacy in the treatment of schizophrenia].
Messer T; Tiltscher C; Schmauss M
Fortschr Neurol Psychiatr; 2006 Jul; 74(7):377-91. PubMed ID: 16804806
[TBL] [Abstract][Full Text] [Related]
16. What is the relationship between schizophrenia and substance abuse?
Green AI
Harv Ment Health Lett; 2000 Oct; 17(4):8. PubMed ID: 11015759
[No Abstract] [Full Text] [Related]
17. Pharmacological treatment of schizophrenia and co-occurring substance use disorders.
Smelson DA; Dixon L; Craig T; Remolina S; Batki SL; Niv N; Owen R
CNS Drugs; 2008; 22(11):903-16. PubMed ID: 18840032
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
19. Substance abuse in schizophrenia: a review.
Buckley PF
J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
[TBL] [Abstract][Full Text] [Related]
20. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
Petrakis IL; Nich C; Ralevski E
Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
